Filing Details
- Accession Number:
- 0001209191-21-002558
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-01-07 17:50:04
- Reporting Period:
- 2021-01-05
- Accepted Time:
- 2021-01-07 17:50:04
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1419600 | Flexion Therapeutics Inc | FLXN | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1296999 | David Arkowitz | C/O Flexion Therapeutics, Inc. 10 Mall Road, Suite 301 Burlington MA 01803 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2021-01-05 | 6,073 | $11.13 | 151,048 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Sale of shares to cover tax withholding obligations associated with the vesting of restricted stock unit awards granted to the Reporting Person on March 1, 2019, and March 2, 2020.
- The weighted average sale price for the transaction reported was $11.13. The shares were sold at a range of prices between $11.12 and $11.47. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.